RenovoRx (RNXT) Return on Equity (2024 - 2025)
RenovoRx (RNXT) has disclosed Return on Equity for 2 consecutive years, with 1.79% as the latest value for Q4 2025.
- Quarterly Return on Equity rose 4.0% to 1.79% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.79% through Dec 2025, up 4.0% year-over-year, with the annual reading at 2.44% for FY2025, N/A changed from the prior year.
- Return on Equity hit 1.79% in Q4 2025 for RenovoRx, down from 1.19% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.91% in Q2 2025 to a low of 1.83% in Q4 2024.